Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

BFKW has developed the Full Sense™ Device – a temporary device that is implanted and extracted via endoscopy and induces long lasting satiety with implanted leading to significant weight loss. This device, once introduced may radically change the current treatment for obesity by eliminating the need for gastric banding, gastric bypass and intragastric balloon surgeries. The Company has strong patent protection with patents issued or in final review (pending) in all of our target markets of the United States (US), European Union (EU), Australia, China and Russia and numerous other jurisdictions.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Zhejiang Yuchen Pharmaceutical Co., Ltd., established on 2005-01-24, The business scope includes the production of Chinese herbal medicine {net system,cut,Cannonball(saute,broil,calcined,Steam),Processing of toxic medicinal materials,Contains pieces for direct consumption}(Operate within the validity period of the drug production license).Operating import and export business;Containing tea products and substitute tea(leaf,flowers,fruit,mixed class),Aquatic product processing(Dried aquatic product packaging),Other processed grain products(processed grains,grain milling products)Production,pack,Purchase and sale of raw medicinal materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zibo Qidingli Patent Information Consulting Co., Ltd., established on 2013-06-03, Business scope includes patent technology consulting,to develop,to promote;advertisement plan(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Hunan Huize Biomedical Technology Co., Ltd., established on 2014-09-25, Business scope includes biomedicine,Research and development of health food,consult,Technology transfer and provision of related technical services in the production process;Preclinical pharmacokinetic research and development,technical consulting,technology transfer;account Serive;Chemical reagents for new drug development,Chemical raw materials(Free of hazardous and monitored chemicals),Sales of electronic instruments.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the manufacture, sale, research and development of household products and medical equipment. It also develops, manufactures, markets, and sells electro-medical equipment in the patient monitoring, laboratory instrument, and medical ultrasound fields. The company was founded by Hang Xu on January 25, 1991 and is headquartered in Shenzhen, China.

CapsoVision is a medical device company that provides a 360° panoramic view of the small bowel, providing you with a direct view of the mucosa instead of down the tunnel allowing visibility of more pathology. It features a cloud-based platform that allows its users to extract data from the CapsoCam Plus capsule without the need to process post-ingestion. It was founded in 2005 and headquartered in Saratoga, California.

Draco provides concrete additives, concrete curing, mold oils, plastering, anchoring, installation, decorative concrete-asphalt, floor coverings, thermal insulation, water isolation, primer, adhesives, ceramic adhesives, protective coatings, and so on.

Pluromed, Inc. develops, manufactures, and markets disposable medical devices based on reverse thermosensitive polymer technology in Europe, Canada, and the United States. It offers LeGoo Internal Vessel Occluder, a liquid polymer for the temporary occlusion of blood vessels; and LeGoo Endovascular Occlusion Gel for clampless vascular and cardiovascular surgery. The company also provides BackStop, an atraumatic device to prevent stone migration and stone fragment retropulsion during ureteroscopic lithotripsy; and Lumagel, an oncology product for cancer therapies, partial nephrectomy, hepatic resection, radiofrequency ablation, and chemotherapy. Its products are used to control bleeding during various surgical and interventional procedures including cardiac and vascular surgery, plastic and reconstructive surgery, kidney and liver cancer therapies, and trauma/battlefield injuries. The company was founded in 2003 and is based in Woburn, Massachusetts. As of April 2, 2012, Pluromed, Inc. operates as a subsidiary of Sanofi.

Python Medical, Inc. develops novel treatments and devices for gastrointestinal disorders. The company was founded on June 6, 2002 and is headquartered in San Jose, CA.

Anhui Jinyuan Agriculture and Animal Husbandry Co., Ltd., established on 2007-10-31, Business scope includes pig breeding,reproduce,farming,Sales,feed,Sales of agricultural and sideline products,chicken,sheep farming,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Anhui Yanzhifang Food Co., Ltd. engages in the processing of whole grains. It offers coarse grains; dried mushrooms, lotus seeds, black fungus, and jujube; and sesame walnut black bean and red bean glutinous rice bran powder. The company was founded on May 25, 2001 and is headquartered in Hefei, China.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.